logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Prediction model shows promise for pathogenic variants in CRC and endometrial cancer

A PREMM5 score at or above 2.5% warrants consideration of multigene panel testing.